Rating Downgrade: Lifecore, Ready To Go, But Problems Remain
Source: SeekingAlpha
2025-10-09 04:52:31 ET
Lifecore Biomedical ( LFCR ) is a fully integrated contract development and manufacturing organization (CDMO). We covered the shares some 10 months ago, so for an introduction to the company, we refer you to that article. What follows is an update....
Read the full article on Seeking Alpha
For further details see:
Rating Downgrade: Lifecore, Ready To Go, But Problems Remain
Lifecore Biomedical Inc.
NASDAQ: LFCR
LFCR Trading
-2.47% G/L:
$6.52 Last:
86,018 Volume:
$6.63 Open:
LFCR Latest News
March 10, 2026 04:05:00 pm
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum
March 09, 2026 04:05:00 pm
Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026
LFCR Stock Data
$276,501,678
20,569,027
4.87%
36
N/A
Biotechnology & Life Sciences
Healthcare
US
Chaska
